CDKN1A and neoplasm: This senescence-associated cell cycle arrest (mostly G1) depends on the activation of the cyclin-dependent kinase (CDK) inhibitors p21/WAF1 and p16/INK4A, the decisive components of tumor-suppressor pathways that are governed by the p53 and retinoblastoma (Rb) proteins, respectively [7,8].